CHEST Annual Meeting 2026
Five IntelliSep Studies. Three Sessions.
October 19-21 | Phoenix | Booth #1246
Join Cytovale at CHEST 2026 to explore five IntelliSep studies across three sessions examining host-response testing and sepsis risk stratification. Stop by Booth #1246 to meet our team, learn more about IntelliSep, and discuss what the research could mean for your practice.
Tuesday, October 20
SEPSIS SANDBOX
Evaluation of a Host-Response Sepsis Diagnostic Test for Risk Stratification of Transplant Recipients Presenting to the Emergency Department with Signs and Symptoms of Infection
1:45–2:30 PM MST | Exhibit Hall, Rapid Fire Area 2A
Dhruvangkumar Modi, MD, MPH, Texas Health Presbyterian Hospital Denton
Wednesday, October 21
Sepsis and Precision Medicine: Biomarkers, Endophenotypes, & Outcomes
An Evaluation of the Differential Diagnosis of Critically Ill Patients at High Risk for Sepsis
8:00–9:00 AM MST | North Building, Room 125 B
Danielle Ledet, MD, LSU Health Sciences Center
Poster Presentations
Evidence, Guidelines and QI Scientific Abstract Posters
10:20–11:05 AM MST | Exhibit Hall, Poster Area 4
| Poster | Study | Presenter |
|---|---|---|
| 4644 | Cellular Host Response-Based Risk Stratification Guiding Antibiotic Deescalation: A Midpilot Quality Improvement Initiative | Rodwan Jomaa, DO Texas Health Resources |
| 4647 | Impact of a Sepsis Early Diagnostic Test on Safe Emergency Department Discharge and Reduction in Emergency Department Overcrowding | Nicholas LeBlanc, MD Our Lady of the Lake Regional Medical Center |
| 4671 | Prevalence of True Bloodstream Infections Among IntelliSep Band 1 Patients: A Single-Center Retrospective Analysis | Scott Yount, MD Our Lady of the Lake Regional Medical Center |
Let’s talk at CHEST
Have questions about IntelliSep, implementation, or how early sepsis risk stratification could support care at your hospital?
Meet with the Cytovale team to discuss the research presented at CHEST and explore what IntelliSep could mean for your organization.
Booth #1246